EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adherence and Treat‐to‐Target Benchmarks in Older Adults With Gout Initiating Urate‐Lowering Therapy in Ontario, Canada: A Population‐Based Study

Timothy S H Kwok iD, Bindee Kuriya iD, Gillian Hawker iD, Lihi Eder iD, Ping Li, Gregory Choy, Jessica Widdifield iD

Arthritis Care & Research · 2024

DOI: 10.1002/acr.25380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2024. Verfasst von Timothy S H Kwok und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto and Sunnybrook Research Institute, Holland Bone & Joint Program, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Gout, Gout Suppressants, Uric Acid, Drug Monitoring. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Physicians' Services Incorporated Foundation, PSI Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We sought to evaluate urate‐lowering therapy (ULT) adherence and treatment‐to‐target (T2T) serum uric acid (SUA) levels among older adults with gout starting ULT.

Methods

We performed a population‐based retrospective cohort study in Ontario, Canada in patients with gout aged ≥66 years newly dispensed ULT between 2010 and 2019. We defined successful T2T as patients having SUA levels 50 mg (OR 2.53, 95% CI 2.14–2.99), colchicine/oral glucocorticoids co‐prescription (OR 1.24, 95% CI 1.14–1.34), and ULT prescription from a rheumatologist.

Conclusion

Only 52.3% of patients achieved an optimal SUA level within 1 year of ULT initiation. ULT adherence was suboptimal, although improving over time. ULT adherence and higher allopurinol starting doses had the strongest associations of achieving a target SUA level. This study highlights room for improvement in gout management and potential strategies to address care gaps.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutGout SuppressantsUric AcidDrug MonitoringHumansMaleFemaleAgedOntarioRetrospective StudiesAged, 80 and overBenchmarkingTreatment OutcomeBiomarkers

Substanzen

Gout SuppressantsUric AcidBiomarkers

Autor:innen und Institutionen

  • University of Toronto and Sunnybrook Research Institute, Holland Bone & Joint Program, Toronto, Ontario, Canada.
  • University of Toronto, Toronto, Ontario, Canada.
  • ICES, Toronto, Ontario, Canada.
  • University of Toronto, Sunnybrook Research Institute, Holland Bone & Joint Program, and ICES, Toronto, Ontario, Canada.

ORCID-Profile: Timothy S H Kwok, Bindee Kuriya, Gillian Hawker, Lihi Eder, Jessica Widdifield

Förderung

  • Physicians' Services Incorporated Foundation
  • PSI Foundation

Zitieren

APA

Kwok, T. S. H., Kuriya, B., Hawker, G., Eder, L., Li, P., Choy, G., & Widdifield, J. (2024). Adherence and Treat‐to‐Target Benchmarks in Older Adults With Gout Initiating Urate‐Lowering Therapy in Ontario, Canada: A Population‐Based Study. Arthritis Care & Research. https://doi.org/10.1002/acr.25380

Vancouver

Kwok TSH, Kuriya B, Hawker G, Eder L, Li P, Choy G, et al. Adherence and Treat‐to‐Target Benchmarks in Older Adults With Gout Initiating Urate‐Lowering Therapy in Ontario, Canada: A Population‐Based Study. Arthritis Care & Research. 2024. doi:10.1002/acr.25380

BibTeX
@article{Kwok2024,
  author = {Kwok, Timothy S H and Kuriya, Bindee and Hawker, Gillian and Eder, Lihi and Li, Ping and Choy, Gregory and Widdifield, Jessica},
  title = {Adherence and Treat‐to‐Target Benchmarks in Older Adults With Gout Initiating Urate‐Lowering Therapy in Ontario, Canada: A Population‐Based Study},
  journal = {Arthritis Care & Research},
  year = {2024},
  doi = {10.1002/acr.25380}
}
Kostenlos starten →